Written by: Hani Judeh, MD, CMO and CMIO, Accuity Healthcare and Stephanie Smith, MD, Vice President, Clinical Intelligence
Healthcare AI is moving from enthusiasm to accountability.
The Health AI Partnership's AI Vendor Disclosure Framework, described in NEJM AI, gives health systems a structured way to evaluate AI vendors across intended use, system performance and compliance, data stewardship, integration, and lifecycle management. That transparency matters — it gives buyers a better way to ask what an AI system actually does before it's purchased and implemented.
For mid–revenue cycle vendors, though, disclosure is only the starting point. The more important question is whether the recommendation can be defended.
That distinction matters because mid–revenue cycle AI doesn't operate at a distance from consequence. It sits inside decisions that affect documentation integrity, coding pathways, reimbursement, denials, payer scrutiny, reviewer burden, and provider trust. A single recommendation may influence whether an opportunity is surfaced, escalated, deprioritized, or acted upon — and hospitals and physicians remain accountable for the decisions they make using vendor AI outputs.
At Accuity, we believe that responsibility requires a higher standard: clinical and coding integrity.
What that standard actually means
Clinical and coding integrity means an AI-supported recommendation should be clinically meaningful, documentation-supported, coding-relevant, and defensible under review. It should be clear why the recommendation was made, what evidence supports it, what uncertainty remains, and whether the case is appropriate for automation or expert review. That is the difference between AI that can be described and AI that can be defended.
Health systems are operating on thin margins, which means they need automation that stays reliable after launch — not automation that creates new volatility. Missed clinically valid findings become revenue leakage. Unsupported recommendations create rework, denials exposure, and payer clawback risk. Prioritization pathways without monitoring can make work disappear from view while risk quietly accumulates.
Stable automation doesn't happen by accident. It requires evidence standards, decision boundaries, monitoring, change control, and rollback criteria. Governance isn't administrative drag. It's how automation stays reliable as documentation patterns, payer behavior, coding guidance, and client workflows shift over time. NIST's AI Risk Management Framework identifies these same measures as core functions of trustworthy AI systems.¹
This is why mid–revenue cycle automation can't be judged by throughput alone. A clinically plausible finding isn't automatically a coding-supported opportunity. A documentation phrase isn't automatically evidence of an active, reportable, reimbursable condition. The work requires careful translation across medicine, documentation, coding guidance, payer scrutiny, and operational workflow — and that translation cannot be left to automation alone.
The collaboration is the control
Accuity's approach combines physician-led clinical logic development, physician-coder adjudication, governance controls, and downstream appeals management for the cases we touch. Physicians and coders bring different but complementary expertise: physicians contribute clinical context, disease understanding, plausibility assessment, and judgment under uncertainty, while coders bring documentation standards, coding guidance, reimbursement logic, and defensibility discipline. Together, they determine whether an AI-supported opportunity is valid and appropriate for action — giving automation both structure and restraint.
Physician-authored logic defines the clinical intent of the technology. Expert judgment determines when evidence is strong enough to act, when uncertainty should stop automation, and when human review is required. That is the Accuity value proposition: not automation for throughput only, but automation governed by the people who understand the clinical and coding consequences of being wrong.
Lineage is where defensibility becomes real
A vendor AI output doesn't remove accountability. The hospital still has to act and respond to scrutiny. The physician still has to stand behind the clinical record. The coding and revenue cycle teams still have to defend the resulting claim.
That's why evidence lineage matters. A recommendation should be traceable from the output back to the record evidence, diagnosis or procedure, coding rationale, and logic or model version that produced it. Mid–revenue cycle decisions don't rest on isolated words — they depend on source, timing, attribution, clinical context, documentation sufficiency, and coding relevance. Lineage allows reviewers and governance teams to understand where the evidence came from, why it mattered, and whether it was strong enough to support action. It also creates the path for error review, drift detection, recurrence tracking, and logic correction.
Accuity extends that defensibility downstream. For the cases we touch, appeals management connects the original recommendation to the evidence, clinical rationale, coding rationale, and payer-facing defense. That matters because defensibility isn't proven when an AI output is generated — it's proven when the recommendation can withstand denial and audit scrutiny. Without lineage, an AI output is an assertion. With lineage and downstream defense, it becomes part of an operating model that can stand behind the work.
The floor and the standard
The HAIP framework is an important step toward more disciplined AI evaluation and procurement in healthcare. But in the mid–revenue cycle, transparency is the floor. Clinical and coding integrity is the standard.
Defensible automation means AI-supported work shaped by physician-authored logic, physician-coder judgment, evidence lineage, lifecycle governance, and appeals support for the cases we touch. That's how automation can reduce burden without hiding risk, support efficiency without sacrificing defensibility, and help protect financial stability in an environment where margins are thin and volatility is costly.
The future of mid–revenue cycle AI won't belong to the largest model or the loudest automation claim. It will belong to systems that can be trusted at the point of use. More defensible AI. Not just more confident AI.
References
- Tabassi E. Artificial Intelligence Risk Management Framework (AI RMF 1.0). NIST AI 100-1. National Institute of Standards and Technology; 2023. https://doi.org/10.6028/NIST.AI.100-1
- Kpodzro S, Kim JY, Hasan A, et al. A collaborative best practice guide for promoting AI vendor transparency in health care — the HAIP AI Vendor Disclosure Framework. NEJM AI. 2026;3(5). https://doi.org/10.1056/AIp2500985
- Health AI Partnership. AI Vendor Disclosure Framework. healthaipartnership.org. https://healthaipartnership.org/haip-ai-vendor-disclosure-framework
- Office of the National Coordinator for Health Information Technology. Health data, technology, and interoperability: certification program updates, algorithm transparency, and information sharing (HTI-1). Final rule. Federal Register. 2024;89(6):1192–1675. https://www.federalregister.gov/documents/2024/01/09/2023-28857